Are you a new member? Sign up now
Login area
| Sign up
close
NOVOMIX 30 - 100IU/ml - 5 x 3ml
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A10AD05 | BioTech | Insulin aspart - 30%, Insulin aspart protamine - 70% | 8111 | 42415/1 | NOVOMIX 30 | 100IU/ml | 5 x 3ml | Injectable suspension | SC | Mersaco | Novo Nordisk Produçao Farmacêutica Do Brazil Ltda | Brazil | 4,264,012 L.L | 23.08 | B | Novo Nordisk AS | Denmark | 12/12/20 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A10AD05 | BioTech | Insulin aspart - 30%, Insulin aspart protamine - 70% | 2016 | 208836/03 | NOVOMIX 30 | 100IU/ml | 5 x 3ml | Injectable suspension | SC | Mersaco | Novo Nordisk AS | Denmark | 4,264,012 L.L | 23.08 | B | 12/12/20 | 0 | ||
| A10AD05 | BioTech | Insulin aspart - 30%, Insulin aspart protamine - 70% | 8085 | 145114/1 | NOVOMIX 30 | 100IU/ml | 5 x 3ml | Injectable suspension | SC | Mersaco | Novo Nordisk Production SAS, Chartres | France | 4,264,012 L.L | 23.08 | B | Novo Nordisk AS | Denmark | 12/12/20 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024